端粒磨损成为老化血液形成和白血病产生中的克隆选择工具
Matthew A McLoughlin1,2,3, Sruthi Cheloor Kovilakam1,2, William G Dunn1,2,3
1Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Nature genetics
|August 28, 2025
概括
克隆造血因子突变与端粒缩短有关,特别是在老年人中. 这些突变可能会保护干细胞免受端粒缩短,从而影响癌症的发展.
科学领域:
- 血液学
- 遗传学
- 老龄化研究
背景情况:
- 链接拼接因子基因突变与克隆造血 (CH) 和骨髓性恶性瘤的机制尚不清楚.
- 结核病,骨髓癌和晚年之间的关联已被确立,但在机理上没有解释.
- 端粒维护是一个关键的生物过程,
研究的目的:
- 研究端粒维持在剪接因子突变的克隆造血过程中的作用.
- 探索端粒长度和CH亚型之间的关系,包括具有拼接因子,PPM1D和TERT促进器突变的亚型.
- 在衰老和遗传突变的背景下,阐明端粒磨损如何影响克隆选择和白血病发生.
主要方法:
- 分析了来自454,098名参与者的英国生物库数据.
- 基因组分析以确定拼接因子基因,PPM1D和TERT中的突变.
- 基因预测的端粒长度与CH亚型之间的相关性分析.
- 研究血造干细胞 (HSC) 中的端粒磨损和拼接因子突变之间的相互作用.
主要成果:
- 与大多数其他CH亚型不同,剪接因子突变的CH在基因预测较短的个体中更为普遍.
- 与PPM1D和TERT基因促进基因突变相关的CH也显示出较短的端粒的更高发病率.
- 端粒磨损作为衰老的选择性压力,剪接因子突变可能拯救HSC从关键的端粒缩短.
结论:
- 端粒维持在整个生命中显著影响造血.
- 拼接因子突变可能通过抵消端粒缩短来驱动白血病发生的共同机制.
- 这些发现为结合因子突变性CH和相关癌症提供了潜在的治疗策略.
相关概念视频
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Replication in Eukaryotes
14.5K
In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
14.5K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Telomeres and Telomerase
5.4K
5.4K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K


